New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 5, 2014
08:03 EDTOXFDOxford Immunotec growth looks robust, says RW Baird
Baird believes the growth outlook for Oxford Immunotec remains robust and they believe the company is in the early stages of penetrating the large global market for latent TB testing. Shares are Outperform rated and price target raised to $27 from $21.
News For OXFD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 25, 2014
13:35 EDTOXFDOxford Immunotec files $125M mixed securities shelf
Subscribe for More Information
November 18, 2014
09:17 EDTOXFDOxford Immunotec management to meet with Piper Jaffary
Meetings to be held in Europe November 19-20 hosted by Piper Jaffray.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use